120 related articles for article (PubMed ID: 8680683)
1. Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults.
Olivier KN; Bennett WD; Hohneker KW; Zeman KL; Edwards LJ; Boucher RC; Knowles MR
Am J Respir Crit Care Med; 1996 Jul; 154(1):217-23. PubMed ID: 8680683
[TBL] [Abstract][Full Text] [Related]
2. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis.
Bennett WD; Olivier KN; Zeman KL; Hohneker KW; Boucher RC; Knowles MR
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1796-801. PubMed ID: 8665037
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
[TBL] [Abstract][Full Text] [Related]
4. Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis.
Bennett WD; Zeman KL; Foy C; Shaffer CL; Johnson FL; Regnis JA; Sannuti A; Johnson J
Am J Respir Crit Care Med; 2001 Jul; 164(2):302-6. PubMed ID: 11463605
[TBL] [Abstract][Full Text] [Related]
5. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
[TBL] [Abstract][Full Text] [Related]
6. Effect of aerosolized uridine-5'-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia.
Noone PG; Bennett WD; Regnis JA; Zeman KL; Carson JL; King M; Boucher RC; Knowles MR
Am J Respir Crit Care Med; 1999 Jul; 160(1):144-9. PubMed ID: 10390392
[TBL] [Abstract][Full Text] [Related]
7. Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects.
Sood N; Bennett WD; Zeman K; Brown J; Foy C; Boucher RC; Knowles MR
Am J Respir Crit Care Med; 2003 Jan; 167(2):158-63. PubMed ID: 12411282
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of amiloride-sensitive epithelial Na(+) absorption by extracellular nucleotides in human normal and cystic fibrosis airways.
Mall M; Wissner A; Gonska T; Calenborn D; Kuehr J; Brandis M; Kunzelmann K
Am J Respir Cell Mol Biol; 2000 Dec; 23(6):755-61. PubMed ID: 11104728
[TBL] [Abstract][Full Text] [Related]
9. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis.
Knowles MR; Clarke LL; Boucher RC
N Engl J Med; 1991 Aug; 325(8):533-8. PubMed ID: 1857389
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
Knowles MR; Olivier K; Noone P; Boucher RC
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
[TBL] [Abstract][Full Text] [Related]
11. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
Middleton PG; Geddes DM; Alton EW
Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871
[TBL] [Abstract][Full Text] [Related]
12. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT
Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593
[TBL] [Abstract][Full Text] [Related]
13. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
App EM; King M; Helfesrieder R; Köhler D; Matthys H
Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
[TBL] [Abstract][Full Text] [Related]
14. [Pilot study of amiloride inhalation in children with cystic fibrosis].
Riedler J; Huttegger I
Klin Padiatr; 1992; 204(3):158-62. PubMed ID: 1614182
[TBL] [Abstract][Full Text] [Related]
15. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
[TBL] [Abstract][Full Text] [Related]
16. Sodium channel blockers and uridine triphosphate: effects on nasal potential difference in cystic fibrosis mice.
Ghosal S; Taylor CJ; Colledge WH; Ratcliff R; Evans MJ
Eur Respir J; 2000 Jan; 15(1):146-50. PubMed ID: 10678637
[TBL] [Abstract][Full Text] [Related]
17. NVP-QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia.
Coote KJ; Paisley D; Czarnecki S; Tweed M; Watson H; Young A; Sugar R; Vyas M; Smith NJ; Baettig U; Groot-Kormelink PJ; Gosling M; Lock R; Ethell B; Williams G; Schumacher A; Harris J; Abraham WM; Sabater J; Poll CT; Faller T; Collingwood SP; Danahay H
Br J Pharmacol; 2015 Jun; 172(11):2814-26. PubMed ID: 25573195
[TBL] [Abstract][Full Text] [Related]
18. [New aspects of therapy of mucoviscidosis (CF)].
Dietzsch HJ; Wunderlich P
Kinderarztl Prax; 1993 Feb; 61(1):19-23. PubMed ID: 8464194
[TBL] [Abstract][Full Text] [Related]
19. Aerosolization of P2Y(2)-receptor agonists enhances mucociliary clearance in sheep.
Sabater JR; Mao YM; Shaffer C; James MK; O'Riordan TG; Abraham WM
J Appl Physiol (1985); 1999 Dec; 87(6):2191-6. PubMed ID: 10601167
[TBL] [Abstract][Full Text] [Related]
20. Validity and safety of sputum induction by inhaled uridine 5'-triphosphate.
Tamaoki J; Kondo M; Kuroda H; Aoshiba K; Takeyama K; Nakata J; Nagai A
Am J Respir Crit Care Med; 2001 Aug; 164(3):378-81. PubMed ID: 11500336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]